$DORM
Dorman Products, Inc.

2017 Q1 Form 10-K Financial Statement

#000119312517058492 Filed on February 27, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 2015 Q4
Revenue $859.6M $204.8M
YoY Change 7.05% 17.73%
Cost Of Revenue $521.5M $127.0M
YoY Change 5.38% 18.36%
Gross Profit $338.1M $77.80M
YoY Change 9.75% 16.64%
Gross Profit Margin 39.33% 37.98%
Selling, General & Admin $169.5M $43.40M
YoY Change 4.68% 13.91%
% of Gross Profit 50.13% 55.78%
Research & Development $18.90M
YoY Change 12.5%
% of Gross Profit 5.59%
Depreciation & Amortization $18.70M $4.500M
YoY Change 17.61% 21.62%
% of Gross Profit 5.53% 5.78%
Operating Expenses $169.5M $43.50M
YoY Change -5.16% 14.17%
Operating Profit $168.6M $34.37M
YoY Change 15.36% 20.13%
Interest Expense $241.0K -$100.0K
YoY Change 11.57%
% of Operating Profit 0.14% -0.29%
Other Income/Expense, Net -$241.0K
YoY Change 11.57%
Pretax Income $168.4M $34.30M
YoY Change 15.36% 19.93%
Income Tax $62.31M $12.50M
% Of Pretax Income 37.01% 36.44%
Net Earnings $106.0M $21.79M
YoY Change 14.86% 16.78%
Net Earnings / Revenue 12.34% 10.64%
Basic Earnings Per Share $3.07
Diluted Earnings Per Share $3.07 $0.62
COMMON SHARES
Basic Shares Outstanding 34.55M shares 34.52M 35.50M shares
Diluted Shares Outstanding 34.60M

Balance Sheet

Concept 2017 Q1 2016 2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $149.1M $78.70M
YoY Change 89.45% 64.99%
Cash & Equivalents $149.1M $78.66M
Short-Term Investments
Other Short-Term Assets $3.100M $2.300M
YoY Change 34.78% -25.81%
Inventory $168.9M $193.7M
Prepaid Expenses
Receivables $230.5M $203.9M
Other Receivables $0.00 $0.00
Total Short-Term Assets $551.6M $478.6M
YoY Change 15.25% 11.22%
LONG-TERM ASSETS
Property, Plant & Equipment $88.40M $87.05M
YoY Change 1.61% 5.81%
Goodwill $28.15M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $42.00M $18.74M
YoY Change 59.7% 48.2%
Total Long-Term Assets $160.2M $143.2M
YoY Change 11.79% 12.47%
TOTAL ASSETS
Total Short-Term Assets $551.6M $478.6M
Total Long-Term Assets $160.2M $143.2M
Total Assets $711.8M $621.9M
YoY Change 14.46% 11.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $72.60M $63.97M
YoY Change 13.44% 7.43%
Accrued Expenses $31.20M $23.63M
YoY Change -9.83% 14.84%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $103.8M $98.57M
YoY Change 5.27% 8.52%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $6.300M $5.259M
YoY Change 18.87% 9.06%
Total Long-Term Liabilities $6.300M $5.259M
YoY Change 18.87% 9.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $103.8M $98.57M
Total Long-Term Liabilities $6.300M $5.259M
Total Liabilities $110.2M $103.8M
YoY Change 6.17% 8.55%
SHAREHOLDERS EQUITY
Retained Earnings $474.9M
YoY Change 13.53%
Common Stock $43.15M
YoY Change -1.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $601.6M $518.0M
YoY Change
Total Liabilities & Shareholders Equity $711.8M $621.9M
YoY Change 14.46% 11.5%

Cashflow Statement

Concept 2017 Q1 2016 2015 Q4
OPERATING ACTIVITIES
Net Income $106.0M $21.79M
YoY Change 14.86% 16.78%
Depreciation, Depletion And Amortization $18.70M $4.500M
YoY Change 17.61% 21.62%
Cash From Operating Activities $121.5M $34.60M
YoY Change 31.96% 183.61%
INVESTING ACTIVITIES
Capital Expenditures $20.06M -$5.200M
YoY Change -7.51% -24.64%
Acquisitions
YoY Change
Other Investing Activities -$6.200M -$100.0K
YoY Change 195.24%
Cash From Investing Activities -$26.25M -$5.300M
YoY Change 10.31% -23.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -24.82M -29.90M
YoY Change -33.27% 1473.68%
NET CHANGE
Cash From Operating Activities 121.5M 34.60M
Cash From Investing Activities -26.25M -5.300M
Cash From Financing Activities -24.82M -29.90M
Net Change In Cash 70.46M -600.0K
YoY Change 126.57% -117.65%
FREE CASH FLOW
Cash From Operating Activities $121.5M $34.60M
Capital Expenditures $20.06M -$5.200M
Free Cash Flow $101.5M $39.80M
YoY Change 44.12% 108.38%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q4 us-gaap Assets Current
AssetsCurrent
478633000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60593000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
413641000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.13
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
109459 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
24.47
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1201000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
141500 shares
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47656000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
462061000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.28
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
72900 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
27.82
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1163000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
75000 shares
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10970000
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
92623000
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34863396 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34863396 shares
CY2015Q4 us-gaap Assets
Assets
621865000
CY2015Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
22731000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
2435000
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
7557000
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
214000
CY2015Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
9524000
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
42799000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78659000
CY2015Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
7557000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
203923000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
349000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
63967000
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
30288000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23633000
CY2015Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
29889000
CY2015Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
500000
CY2015Q4 us-gaap Inventory Net
InventoryNet
193725000
CY2015Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
14600000
CY2015Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
78533000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
621865000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5259000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
98570000
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
112012000
CY2015Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
3180000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18740000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
87046000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
179669000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
518036000
CY2015Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
8685000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.86
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
43242 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
34.49
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1855000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
474888000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2326000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
40000 shares
CY2015Q4 dorm Number Of Largest Customer
NumberOfLargestCustomer
5 Customer
CY2015Q4 dorm Accrued Customer Rebates
AccruedCustomerRebates
15000000
CY2015Q4 dorm Receivables Not Sold Additional Receivables Outstanding
ReceivablesNotSoldAdditionalReceivablesOutstanding
335900000
CY2015Q4 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
86986000
CY2015Q4 dorm Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
13207000
CY2015Q4 dorm Deferred Tax Assets Accounts Receivable
DeferredTaxAssetsAccountsReceivable
18954000
CY2015Q4 dorm Number Of Foreign Forward Contracts Outstanding
NumberOfForeignForwardContractsOutstanding
0 Contract
CY2017Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
34547089 shares
CY2016Q2 dei Entity Public Float
EntityPublicFloat
1407837036
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11899000
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
105729000
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34517633 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34517633 shares
CY2016Q4 us-gaap Assets
Assets
711792000
CY2016Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
21845000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
2935000
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
12429000
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
786000
CY2016Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
9857000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
551614000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
44187000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
149121000
CY2016Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
12429000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
230526000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
345000
CY2016Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
50000000 shares
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
72629000
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
34274000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19320000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
15168000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1799000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1847000
CY2016Q4 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.0142 pure
CY2016Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
29788000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
4149000
CY2016Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
500000
CY2016Q4 us-gaap Inventory Net
InventoryNet
168851000
CY2016Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
18500000
CY2016Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
72833000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
711792000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6302000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
103848000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
1757000
CY2016Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
29000000
CY2016Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
30000000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1892000
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
93223000
CY2016Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
2795000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
29525000
CY2016Q4 us-gaap Line Of Credit
LineOfCredit
0
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4401521
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
3724000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
88436000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
194165000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
601642000
CY2016Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
10337000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
29.52
CY2016Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
6.86
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
40000 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
145363 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
49.22
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3567000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
557110000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1518637 shares
CY2016Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
29.52
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3116000
CY2016Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
40000 shares
CY2016Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
200000
CY2016Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
2500000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
2000000 shares
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2648120
CY2016Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
101084 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
101084 shares
CY2016Q4 dorm Number Of Largest Customer
NumberOfLargestCustomer
5 Customer
CY2016Q4 dorm Accrued Customer Rebates
AccruedCustomerRebates
7300000
CY2016Q4 dorm Receivables Not Sold Additional Receivables Outstanding
ReceivablesNotSoldAdditionalReceivablesOutstanding
338300000
CY2016Q4 dorm Number Of Outstanding Letters Of Credit
NumberOfOutstandingLettersOfCredit
2 LetterOfCredit
CY2016Q4 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
99995000
CY2016Q4 dorm Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
11988000
CY2016Q4 dorm Number Of Common Stock Held Under Retirement Plan
NumberOfCommonStockHeldUnderRetirementPlan
288738 shares
CY2016Q4 dorm Deferred Tax Assets Accounts Receivable
DeferredTaxAssetsAccountsReceivable
20216000
CY2016Q4 dorm Common Stock Held By Relatives Of Director Percentage
CommonStockHeldByRelativesOfDirectorPercentage
0.21 pure
CY2016Q4 dorm Number Of Foreign Forward Contracts Outstanding
NumberOfForeignForwardContractsOutstanding
0 Contract
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
48293000
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
51175000
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5000 shares
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1146000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-12937000
CY2014 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
12658000
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.012 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.004 pure
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-597000
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-35000
CY2014 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.50
CY2014 us-gaap Depreciation
Depreciation
12200000
CY2014 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.49
CY2014 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.002 pure
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-632000
CY2014 us-gaap Cost Of Goods Sold
CostOfGoodsSold
464275000
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2882000
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.360 pure
CY2014 dorm Stock Repurchased And Retired During Period Average Purchase Price
StockRepurchasedAndRetiredDuringPeriodAveragePurchasePrice
50.71
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2014 us-gaap Sales Revenue Net
SalesRevenueNet
751476000
CY2014 us-gaap Interest Paid
InterestPaid
234000
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
4100000
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1500000
CY2014 us-gaap Gross Profit
GrossProfit
287201000
CY2014 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1558000
CY2014 us-gaap Net Income Loss
NetIncomeLoss
89987000
CY2014 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
308000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
140530000
CY2014 us-gaap Interest Expense
InterestExpense
204000
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-29862000
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
25566000
CY2014 us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
6200000
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
522000
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13136000
CY2014 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
6757000
CY2014 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
138000 shares
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
140734000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-42715000
CY2014 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
46540000
CY2014 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
3712000
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
50543000
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
59640000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29862000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
48.29
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
51.41
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
66500 shares
CY2014 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
343000
CY2014 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
463000
CY2014 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36190000 shares
CY2014 us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
477900000
CY2014 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
146467000
CY2014 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
61830 shares
CY2014 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
43519000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
41619 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
21287 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
23.44
CY2014 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
3100000
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
301000
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.97
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36052000 shares
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
1146000
CY2014 us-gaap Restricted Stock Expense
RestrictedStockExpense
1100000
CY2014 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
38000
CY2014 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
301000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
26347 shares
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
463000
CY2014 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
2500000
CY2014 dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
43521000
CY2014 dorm Entity Wide Revenue Major Customer Aggregate Percentage
EntityWideRevenueMajorCustomerAggregatePercentage
0.60 pure
CY2014 dorm Export Sales
ExportSales
39100000
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
53612000
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
92060000
CY2014 dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
343000
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
55140000
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
58718000
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7500 shares
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
882000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
31003000
CY2015 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
16186000
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.018 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.002 pure
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-4874000
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-232000
CY2015 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.60
CY2015 us-gaap Depreciation
Depreciation
15900000
CY2015 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.60
CY2015 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.001 pure
CY2015 us-gaap Cost Of Goods Sold
CostOfGoodsSold
494907000
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3578000
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.367 pure
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5106000
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2015 us-gaap Sales Revenue Net
SalesRevenueNet
802957000
CY2015 us-gaap Interest Paid
InterestPaid
281000
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
4500000
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1600000
CY2015 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
2133000
CY2015 us-gaap Gross Profit
GrossProfit
308050000
CY2015 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
5389000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
92329000
CY2015 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3260000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
145941000
CY2015 us-gaap Interest Expense
InterestExpense
216000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-23821000
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1148000
CY2015 us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
7200000
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-821000
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
20202000
CY2015 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3962000
CY2015 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
72000 shares
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
146157000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-37236000
CY2015 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
57151000
CY2015 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
3611000
CY2016 dei Entity Central Index Key
EntityCentralIndexKey
0000868780
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21688000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
44.84
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
45.68
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
35000 shares
CY2015 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-5000
CY2015 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
93000
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35538000 shares
CY2015 us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
519200000
CY2015 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
161893000
CY2015 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
33430 shares
CY2015 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
37324000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
38580 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
35182 shares
CY2015 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
177000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
25.24
CY2015 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1600000
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
889000
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.76
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35466000 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
44104 shares
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
93000
CY2015 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
2500000
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
882000
CY2015 us-gaap Restricted Stock Expense
RestrictedStockExpense
900000
CY2015 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
20000
CY2015 dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
37324000
CY2015 dorm Entity Wide Revenue Major Customer Aggregate Percentage
EntityWideRevenueMajorCustomerAggregatePercentage
0.60 pure
CY2015 dorm Export Sales
ExportSales
49800000
CY2015 dorm Stock Repurchased And Retired During Period Average Purchase Price
StockRepurchasedAndRetiredDuringPeriodAveragePurchasePrice
48.14
CY2015 dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
-5000
CY2016 dei Entity Registrant Name
EntityRegistrantName
Dorman Products, Inc.
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
61251000
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
67199000
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27000 shares
CY2016 dei Document Type
DocumentType
10-K
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.022 pure
CY2016 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2016 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.002 pure
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-4563000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2380000
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-12-31
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
70462000
CY2016 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
18907000
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-325000
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2016 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.07
CY2016 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 8%"> <b>Concentrations of Risk</b>. Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash equivalents and accounts receivable. All cash equivalents are managed within established guidelines which limit the amount which may be invested with one issuer. A significant percentage of our accounts receivable have been, and will continue to be, concentrated among a relatively small number of automotive retailers and warehouse distributors in the United States. Our five largest customers accounted for 87% of net accounts receivable as of December&#xA0;31, 2016 and 79% of net accounts receivable as of December&#xA0;26, 2015. We continually monitor the credit terms and credit limits to these and other customers. In fiscal 2016, approximately 77% of our products were purchased from suppliers located in a variety of foreign countries, with the largest portion coming from China.</p> </div>
CY2016 us-gaap Depreciation
Depreciation
18700000
CY2016 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2016 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.07
CY2016 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2016 us-gaap Cost Of Goods Sold
CostOfGoodsSold
521530000
CY2016 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
5948000
CY2016 us-gaap Sales Revenue Net
SalesRevenueNet
859604000
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.370 pure
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4888000
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2016 us-gaap Interest Paid
InterestPaid
266000
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
4200000
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1600000
CY2016 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
6195000
CY2016 us-gaap Gross Profit
GrossProfit
338074000
CY2016 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
8662000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
106049000
CY2016 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1221000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
168360000
CY2016 us-gaap Interest Expense
InterestExpense
241000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-26254000
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
27824000
CY2016 us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
8900000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
790000
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-24874000
CY2016 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4590000
CY2016 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
82000 shares
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
168601000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-24823000
CY2016 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
62348000
CY2016 dorm Lease Effective Date
LeaseEffectiveDate
2018-01-01
CY2016 dorm Number Of Largest Customers
NumberOfLargestCustomers
4 Customer
CY2016 dorm Entity Wide Revenue Major Customer Aggregate Percentage
EntityWideRevenueMajorCustomerAggregatePercentage
0.60 pure
CY2016 dorm Export Sales
ExportSales
48600000
CY2016 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2462000
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
62311000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
121539000
CY2016 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2022-12-31
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20059000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
33.79
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
49.45
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 8%"> <b>Use of Estimates in the Preparation of Financial Statements</b>. The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> </div>
CY2016 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-145000
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34598000 shares
CY2016 us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
521900000
CY2016 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
169473000
CY2016 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
38970 shares
CY2016 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
24678000
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
44.36
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
29002 shares
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
2671 shares
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y3M18D
CY2016 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
109000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
29.74
CY2016 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2200000
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
2033000
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34516000 shares
CY2016 dei Trading Symbol
TradingSymbol
DORM
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
133794 shares
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.26 pure
CY2016 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
2500000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.009 pure
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
2380000
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y
CY2016 us-gaap Restricted Stock Expense
RestrictedStockExpense
2300000
CY2016 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P3Y
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
61084 shares
CY2016 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
212000
CY2016 dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
24678000
CY2016 dorm Stock Repurchased And Retired During Period Average Purchase Price
StockRepurchasedAndRetiredDuringPeriodAveragePurchasePrice
56.66
CY2016 dorm Line Of Credit Facility Expiration Month And Year
LineOfCreditFacilityExpirationMonthAndYear
2017-06
CY2016 dorm Maximum Grant Period From Date Of Plan Approval
MaximumGrantPeriodFromDateOfPlanApproval
P10Y
CY2016 dorm Short Term Investment Original Maturity Period Description
ShortTermInvestmentOriginalMaturityPeriodDescription
Three months or less
CY2016 dorm Date Of Plan Approval
DateOfPlanApproval
2009-05-20
CY2016 dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
-145000
CY2015Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
CY2015Q4 us-gaap Sales Revenue Net
SalesRevenueNet
204834000
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
21787000
CY2015Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
34370000
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.60
CY2015Q1 us-gaap Sales Revenue Net
SalesRevenueNet
188474000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
21339000
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
33652000
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
38931000
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
CY2015Q2 us-gaap Sales Revenue Net
SalesRevenueNet
198721000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
23143000
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
36895000
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.73
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
210928000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
26060000
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
41240000
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
208148000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
24671000
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.75
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
209573000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
25982000
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
40989000
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.77
CY2016Q3 us-gaap Sales Revenue Net
SalesRevenueNet
212786000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
26695000
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
41633000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
us-gaap Sales Revenue Net
SalesRevenueNet
229097000
us-gaap Net Income Loss
NetIncomeLoss
28701000
us-gaap Operating Income Loss
OperatingIncomeLoss
47048000

Files In Submission

Name View Source Status
0001193125-17-058492-index-headers.html Edgar Link pending
0001193125-17-058492-index.html Edgar Link pending
0001193125-17-058492.txt Edgar Link pending
0001193125-17-058492-xbrl.zip Edgar Link pending
d293461d10k.htm Edgar Link pending
d293461dex21.htm Edgar Link pending
d293461dex23.htm Edgar Link pending
d293461dex311.htm Edgar Link pending
d293461dex312.htm Edgar Link pending
d293461dex32.htm Edgar Link pending
dorm-20161231.xml Edgar Link completed
dorm-20161231.xsd Edgar Link pending
dorm-20161231_cal.xml Edgar Link unprocessable
dorm-20161231_def.xml Edgar Link unprocessable
dorm-20161231_lab.xml Edgar Link unprocessable
dorm-20161231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g293461g0217075919703.jpg Edgar Link pending
g293461g0217084301567.jpg Edgar Link pending
g293461g0217084301645.jpg Edgar Link pending
g293461g0217084301723.jpg Edgar Link pending
g293461g0217084301802.jpg Edgar Link pending
g293461g0217084301880.jpg Edgar Link pending
g293461g0217084301958.jpg Edgar Link pending
g293461g0217084302036.jpg Edgar Link pending
g293461g0217084302098.jpg Edgar Link pending
g293461g0217084305094.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending